Literature DB >> 25736987

Oral syphilis: report of three cases and characterization of the inflammatory cells.

Luciana Rocha Strieder1, Jorge Esquiche León2, Yasmin Rodarte Carvalho3, Estela Kaminagakura4.   

Abstract

Syphilis is a sexually transmitted infectious disease caused by Treponema pallidum. This study reports 3 cases of syphilis and highlights the importance of identifying oral lesions for its final diagnosis. Case 1: a 48-year-old male patient presented with a bleeding ulcer in the lower lip. Overall clinical examination revealed patchy alopecia and skin target lesions. Case 2: a 61-year-old male patient presented with white spots on the lateral tongue and nodules on the dorsum of the tongue. Overall clinical examination showed erythematous target lesions on the abdomen, forearm, palms of the hand, and soles of the feet. Case 3: a 17-year-old male patient presented with an ulcerated lesion on the tongue and lymph node involvement. The following serologic tests were requested: Venereal Disease Research Laboratory, fluorescent treponemal antibody-absorption, anti-HIV-1 and anti-HIV-2, and anti-hepatitis C virus. An incisional biopsy revealed epithelial hyperplasia associated with intense and diffuse mononuclear inflammatory cell infiltration consisting mainly of plasma cells, in a perivascular and perineural distribution. The final diagnosis in the 3 patients was syphilis. Treatment consisted of 1 weekly dose of penicillin (2.4 million units, intramuscular) for 2 or 3 weeks. Immunohistochemical reactions for XIIIa, CD3, CD20, CD68, CD163, S100, CD1a, CD11c, CD83, CD138, and CD208 were performed. Clinicians should be familiarized with oral syphilis lesions in order to be able to diagnose this emerging infectious disease of variable clinical presentation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infection disease; Sexually transmitted diseases; Treponema pallidum

Mesh:

Year:  2015        PMID: 25736987     DOI: 10.1016/j.anndiagpath.2015.01.003

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  A Case of Isolated Oral Secondary Syphilis.

Authors:  Kiyozumi Suzuki; Akihiro Kanzawa; Hiromasa Otsuka; Yuji Hirai
Journal:  JMA J       Date:  2021-12-08

Review 2.  Oral Manifestations of Syphilis: a Review of the Clinical and Histopathologic Characteristics of a Reemerging Entity with Report of 19 New Cases.

Authors:  Molly Housley Smith; Richard J Vargo; Elizabeth Ann Bilodeau; K Mark Anderson; Anna Trzcinska; Carleigh R Canterbury; John E Fantasia; Yeshwant B Rawal
Journal:  Head Neck Pathol       Date:  2021-01-18

3.  Secondary Syphilis Presenting as Glossodynia, Plaques en Prairie Fauchée, and a Split Papule at the Oral Commissure: Case Report and Review.

Authors:  Walter de Araujo Eyer-Silva; Maria Alessandra Leite Freire; Cecília Angelina Horta-Araujo; Guilherme Almeida Rosa da Silva; Jorge Francisco da Cunha Pinto; Fernando Raphael de Almeida Ferry
Journal:  Case Rep Med       Date:  2017-07-12

4.  Secondary Syphilis with Tonsillar and Cervical Lymphadenopathy and a Pulmonary Lesion Mimicking Malignant Lymphoma.

Authors:  Yukiko Komeno; Yasunori Ota; Tomohiko Koibuchi; Yoichi Imai; Kuniko Iihara; Tomiko Ryu
Journal:  Am J Case Rep       Date:  2018-03-04

5.  Extragenital Chancre in Men Who Have Sex with Men: Six Cases from China.

Authors:  Qian Zhang; Si Chen; Bao Chai; Fei Li; Peng Wang; Qing Li; Xia Wang; Yingmei Zhou; Yuan Lu
Journal:  Arch Sex Behav       Date:  2022-09-29

6.  Unexpected Reason for Non-healing Oral Ulcers: Syphilis.

Authors:  Frank Deng; Lester D R Thompson; Jinping Lai
Journal:  Head Neck Pathol       Date:  2021-08-03

7.  IFNγ Enhances CD64-Potentiated Phagocytosis of Treponema pallidum Opsonized with Human Syphilitic Serum by Human Macrophages.

Authors:  Kelly L Hawley; Adriana R Cruz; Sarah J Benjamin; Carson J La Vake; Jorge L Cervantes; Morgan LeDoyt; Lady G Ramirez; Daniza Mandich; Mary Fiel-Gan; Melissa J Caimano; Justin D Radolf; Juan C Salazar
Journal:  Front Immunol       Date:  2017-10-05       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.